Preface| Volume 34, ISSUE 1, Pxv-xvi, February 2020

Disease Sites

Published:October 28, 2019DOI:
      Radiotherapy remains one of the most common, although misunderstood, tools in the oncology management arsenal as up to two-thirds of all patients receive this modality at some point during their cancer continuum. Radiation Oncology is a rapidly evolving specialty, with substantial innovation in the technical and clinical aspects of radiation treatment over recent years. This 2-part series aims to update practicing oncologists and associated care team members on many of the exciting changes that are taking place in this field.
      This issue of Hematology/Oncology Clinics of North America discusses the role of radiation medicine as part of curative and palliative management for both solid and hematologic malignancies. It updates readers on current clinical trials that include radiotherapy as an integral component of management. The contributors comprise the brightest minds within our specialty. Moreover, they have written each article with the expressed intent of educating nonradiation medicine clinicians on the topic at hand with an eye toward the future.
      We would like to thank all of our authors for their efforts in making this a successful endeavor. We would also like to acknowledge Kristen Helm, Stacy Eastman, and the team at Elsevier for their generous contributions of time, talent, expertise, and discipline to ensure an outstanding pair of issues of the Hematology/Oncology Clinics of North America.